Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions.
Saved in:
| Title: | Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions. |
|---|---|
| Authors: | Yoon C; Interdisciplinary Postgraduate Program in Biomedical Engineering, Graduate School, Jeju National University, Jeju, Republic of Korea., Na E; Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea., Choi MJ; Interdisciplinary Postgraduate Program in Biomedical Engineering, Graduate School, Jeju National University, Jeju, Republic of Korea., Yoon SP; Interdisciplinary Postgraduate Program in Biomedical Engineering, Graduate School, Jeju National University, Jeju, Republic of Korea.; Department of Anatomy, College of Medicine, Jeju National University, Jeju, Republic of Korea. |
| Source: | Oncology research [Oncol Res] 2026 Apr 22; Vol. 34 (5), pp. 23. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1555-3906 |
|---|---|
| DOI: | 10.32604/or.2026.074140 |
